Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 261-270 of 406 for multiple

Edit search filters
  1. The Influence of SSRI’s in Multiple System Atrophy

    Rochester, MN

  2. A Study to Evaluate Sex Differences in Multiple Sclerosis Spectrum of Demyelinating Disorders

    Rochester, MN

  3. A Study Of The Safety And Use Of Tecfidera In Routine Medical Practice For The Treatment Of Multiple Sclerosis

    La Crosse, WI

  4. Development Of A Normal Hematologic Resource For The Aging Mechanisms In Myeloma, Amyloid, And Dysproteinemia Diseases

    Rochester, MN

  5. A Study of the Prevalence and Characteristics of Multiple Sclerosis Related Hypothermia

    Rochester, MN

  6. A Study To Evaluate Diarrhea In Patients With Multiple Myeloma Receiving Conditioning Chemotherapy For Autologous Stem Cell Transplantation (SCT)

    Rochester, MN

  7. The Impact of Clinical Trials in Patients with Multiple Myeloma and Lymphoma

    Rochester, MN

  8. Pragmatic Comparative Clinical Trial To Determine Optimal Initial Therapy For Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, La Crosse, WI, Rochester, MN

  9. American Society of Hematology Research Collaborative’s Data Hub Multiple Myeloma Program

    Rochester, MN

  10. Solitary Bone Plasmacytomas To Elucidate Their Pathogenesis And Risk Of Progression To Multiple Myeloma

    Rochester, MN

.

Mayo Clinic Footer